IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Agricultural chemicals

Evogene files for IPO worth up to $60 million

12:10 PM MDT | September 24, 2013 | Rebecca Coons

Evogene (Rehovot, Israel), a plant genomics firm in which Monsanto and Bayer hold 8.7% and 4.6% stakes, respectively, announced today that it has filed a registration statement with the United States SEC for a proposed initial public offering worth up to $60 million. Additional terms have not been disclosed. According to an F-1 filing, Evogene intends to use approximately half of the proceeds to expedite the commercialization of seed traits and expand its seed traits project portfolio into new traits and crops. The remaining funds will be used to establish...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa